Lexicon Pharmaceuticals
LXRX
#7493
Rank
HK$3.29 B
Marketcap
HK$9.06
Share price
-19.44%
Change (1 day)
52.98%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$0.67 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are HK$0.67 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$1.18 B11.18%
2023-12-31HK$1.06 B76.56%
2022-12-31HK$0.60 B231.69%
2021-12-31HK$0.18 B-50.54%
2020-12-31HK$0.36 B-84.3%
2019-12-31HK$2.34 B-3.73%
2018-12-31HK$2.43 B-15.48%
2017-12-31HK$2.87 B16.6%
2016-12-31HK$2.46 B-13.04%
2015-12-31HK$2.83 B95.26%
2014-12-31HK$1.45 B80.21%
2013-12-31HK$0.80 B-1.01%
2012-12-31HK$0.81 B-21.1%
2011-12-31HK$1.03 B10.7%
2010-12-31HK$0.93 B27.62%
2009-12-31HK$0.73 B44%
2008-12-31HK$0.50 B-21.31%
2007-12-31HK$0.64 B-20.84%
2006-12-31HK$0.81 B-20.93%
2005-12-31HK$1.03 B46.71%
2004-12-31HK$0.70 B-23.19%
2003-12-31HK$0.91 B267.96%
2002-12-31HK$0.24 B47.44%
2001-12-31HK$0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
HK$405.21 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$29.65 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$71.96 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$9.17 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$4.11 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.37 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$4.21 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.17 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$20.32 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA